- Home
- PET vs CLNN Comparison
PET vs CLNN Comparison
Compare PET & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PET
- CLNN
- Stock Information
- Founded
- PET 2015
- CLNN 2012
- Country
- PET United States
- CLNN United States
- Employees
- PET N/A
- CLNN N/A
- Industry
- PET EDP Services
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- PET Technology
- CLNN Health Care
- Exchange
- PET Nasdaq
- CLNN Nasdaq
- Market Cap
- PET 10.7M
- CLNN 43.0M
- IPO Year
- PET N/A
- CLNN N/A
- Fundamental
- Price
- PET $0.20
- CLNN $4.01
- Analyst Decision
- PET Strong Buy
- CLNN Strong Buy
- Analyst Count
- PET 5
- CLNN 4
- Target Price
- PET $4.40
- CLNN $55.25
- AVG Volume (30 Days)
- PET 6.8M
- CLNN 86.9K
- Earning Date
- PET 11-13-2024
- CLNN 11-13-2024
- Dividend Yield
- PET N/A
- CLNN N/A
- EPS Growth
- PET N/A
- CLNN N/A
- EPS
- PET N/A
- CLNN N/A
- Revenue
- PET $76,747,000.00
- CLNN $421,000.00
- Revenue This Year
- PET N/A
- CLNN N/A
- Revenue Next Year
- PET $13.90
- CLNN N/A
- P/E Ratio
- PET N/A
- CLNN N/A
- Revenue Growth
- PET N/A
- CLNN N/A
- 52 Week Low
- PET $0.14
- CLNN $3.82
- 52 Week High
- PET $2.47
- CLNN $12.00
- Technical
- Relative Strength Index (RSI)
- PET 22.33
- CLNN 36.13
- Support Level
- PET $0.18
- CLNN $3.85
- Resistance Level
- PET $0.23
- CLNN $4.53
- Average True Range (ATR)
- PET 0.05
- CLNN 0.46
- MACD
- PET 0.01
- CLNN -0.04
- Stochastic Oscillator
- PET 25.61
- CLNN 13.70
About PET Wag! Group Co.
Wag Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent Pet Caregivers to connect with pet parents. The platform allows pet parents to make pet service requests in the platform, which can then be fulfilled by Pet Caregivers. Wag supports dog walking, pet sitting, pet boarding, drop-in visits at the pet parent's home, advice from licensed pet experts, training services, pet insurance comparison tools, and pet wellness plans.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).